Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

CompletedOBSERVATIONAL

Enrollment

263

Participants

Timeline

Start Date

May 24, 2019

Primary Completion Date

April 7, 2021

Study Completion Date

April 7, 2021

Conditions

Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis

Interventions

OTHER

NAFLD/NASH

the characteristics of patients with advanced fibrosis in a community-based referral center.

Trial Locations (1)

Methodist Dallas Medical Center, Dallas

All Listed Sponsors

lead

Methodist Health System

OTHER

NCT05357352 - Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis | Biotech Hunter | Biotech Hunter